title: Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers' Urine by High Throughput Liquid Chromatography-Mass Spectrometry.
abstract: Nicotine is the most abundant alkaloid in tobacco accounting for 95% of the alkaloid content. There are also several minor tobacco alkaloids; among these are nornicotine, anatabine, and anabasine. We developed and applied a 96 well plate-based capillary LC-tandem mass spectrometry method for the analysis of nornicotine, anatabine, and anabasine in urine. The method was validated with regard to accuracy and precision. Anabasine was quantifiable to low levels with a limit of quantitation (LOQ) of 0.2 ng/mL even when nicotine, which is isobaric, is present at concentrations >2500-fold higher than anabasine. This attribute of the method is important since anatabine and anabasine in urine have been proposed as biomarkers of tobacco use for individuals using nicotine replacement therapies. In the present study, we analyzed the three minor tobacco alkaloids in urine from 827 smokers with a wide range of tobacco exposures. Nornicotine (LOQ 0.6 ng/mL) was detected in all samples, and anatabine (LOQ, 0.15 ng/mL) and anabasine were detected in 97.7% of the samples. The median urinary concentrations of nornicotine, anatabine, and anabasine were 98.9, 4.02, and 5.53 ng/mL. Total nicotine equivalents (TNE) were well correlated with anatabine (r(2) = 0.714) and anabasine (r(2) = 0.760). TNE was most highly correlated with nornicotine, which is also a metabolite of nicotine. Urine samples from a subset of subjects (n = 110) were analyzed for the presence of glucuronide conjugates by quantifying any increase in anatabine and anabasine concentrations after β-glucuronidase treatment. The median ratio of the glucuronidated to free anatabine was 0.74 (range, 0.1 to 10.9), and the median ratio of glucuronidated to free anabasine was 0.3 (range, 0.1 to 2.9). To our knowledge, this is the largest population of smokers for whom the urinary concentrations of these three tobacco alkaloids has been reported.
authors.affiliation: Department of Biochemistry Molecular Biology and Biophysics and Masonic Cancer Center, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Linda B
authors.initials: LB
authors.lastname: von Weymarn
authors.affiliation: Department of Biochemistry Molecular Biology and Biophysics and Masonic Cancer Center, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Thomson
authors.affiliation: Department of Psychology, University of Pittsburgh , Pittsburgh, Pennsylvania 15260, United States.
authors.forename: Eric C
authors.initials: EC
authors.lastname: Donny
authors.affiliation: Masonic Cancer Center and Department of Psychiatry, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Dorothy K
authors.initials: DK
authors.lastname: Hatsukami
authors.affiliation: Department of Biochemistry Molecular Biology and Biophysics and Masonic Cancer Center, University of Minnesota , Minneapolis, Minnesota 55455, United States.
authors.forename: Sharon E
authors.initials: SE
authors.lastname: Murphy
mesh_terms: D000293:Adolescent; D000470:Alkaloids / Q000652:urine*; D000691:Anabasine / Q000652:urine*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D015394:Molecular Structure; D009538:Nicotine / Q000031:analogs & derivatives* / Q000652:urine; D011725:Pyridines / Q000652:urine*; D012907:Smoking / Q000652:urine*; D053719:Tandem Mass Spectrometry
chemical_list: D000470:Alkaloids; D011725:Pyridines; C012737:anatabine; D009538:Nicotine; C005311:nornicotine; D000691:Anabasine
references.citation: J Chromatogr. 1993 Sep 8;619(1):49-61
references.pmid: 8245163
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):1-8
references.pmid: 17644451
references.citation: Am J Clin Pathol. 2006 Dec;126(6):880-7
references.pmid: 17074683
references.citation: Methods Mol Biol. 2010;603:389-98
references.pmid: 20077091
references.citation: J Vet Diagn Invest. 1993 Jul;5(3):498-9
references.pmid: 8373874
references.citation: Anal Chem. 2013 Mar 19;85(6):3380-4
references.pmid: 23394466
references.citation: Am J Public Health. 1999 May;89(5):731-6
references.pmid: 10224986
references.citation: Clin Chim Acta. 2014 Sep 25;436:290-7
references.pmid: 24968308
references.citation: J Agric Food Chem. 1977 Jul-Aug;25(4):752-6
references.pmid: 881495
references.citation: Pharmacol Rev. 2005 Mar;57(1):79-115
references.pmid: 15734728
references.citation: J Anal Toxicol. 2014 Sep;38(7):416-20
references.pmid: 24939383
references.citation: N Engl J Med. 2015 Oct;373(14):1340-9
references.pmid: 26422724
references.citation: MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1108-12
references.pmid: 25426653
references.citation: Handb Exp Pharmacol. 2009;(192):29-60
references.pmid: 19184645
references.citation: Carcinogenesis. 2014 Nov;35(11):2526-33
references.pmid: 25233931
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1668-73
references.pmid: 12496059
references.citation: PLoS One. 2014 Jul 11;9(7):e101816
references.pmid: 25013964
references.citation: Clin Chem. 2004 Dec;50(12):2323-30
references.pmid: 15472033
references.citation: Tob Control. 2013 May;22 Suppl 1:i14-7
references.pmid: 23591498
references.citation: Anal Chem. 2002 Oct 1;74(19):4878-84
references.pmid: 12380807
references.citation: Clin Chem. 2002 Sep;48(9):1460-71
references.pmid: 12194923
references.citation: Phytochemistry. 2013 Oct;94:10-27
references.pmid: 23953973
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10 ):1617-23
references.pmid: 15466978
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 15;878(9-10):725-37
references.pmid: 20097626
references.citation: J Pharm Pharmacol. 1972 Feb;24(2):115-20
references.pmid: 4401964